These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8525934

  • 21. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs.
    Rioux N, Castonguay A.
    J Natl Cancer Inst; 1997 Jun 18; 89(12):874-80. PubMed ID: 9196254
    [Abstract] [Full Text] [Related]

  • 22. [NON-STEROID ANTI-INFLAMMATORY AGENTS. I. DERIVATIVES OF 4- AND 5-AMINOSALICYLIC ACIDS].
    DELBARRE F, BUU-HOUI NP, JACQUIGNON P, BROUILHET H, KAHAN A, MARTY M.
    Med Exp Int J Exp Med; 1964 Jun 18; 11():325-32. PubMed ID: 14226551
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Mesalazine].
    Netzer P.
    Dtsch Med Wochenschr; 1996 Jan 05; 121(1-2):42. PubMed ID: 8565806
    [No Abstract] [Full Text] [Related]

  • 25. The effect of 5-aminosalicylic acid on the mucosal immune system.
    Elitsur Y.
    Gastroenterology; 1992 Mar 05; 102(3):1093-4. PubMed ID: 1599548
    [No Abstract] [Full Text] [Related]

  • 26. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A, Yoshida Y, Muto T, Tsuchiya S, Fukushima T, Hiwatashi N, Kobayashi K, Kitano A, Shimoyama T, Inoue M.
    J Gastroenterol; 1995 Nov 05; 30 Suppl 8():108-11. PubMed ID: 8563868
    [Abstract] [Full Text] [Related]

  • 27. Mesalazine-associated interstitial nephritis.
    Mani V.
    Nephrol Dial Transplant; 1997 Mar 05; 12(3):622-3. PubMed ID: 9075162
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas.
    Campieri M, Lanfranchi GA, Bazzocchi G, Brignola C, Sarti F, Franzin G, Battocchia A, Labo G, Dal Monte PR.
    Lancet; 1981 Aug 08; 2(8241):270-1. PubMed ID: 6114321
    [No Abstract] [Full Text] [Related]

  • 29. Immunopotentiating activity of septilin.
    Praveenkumar V, Kuttan R, Kuttan G.
    Indian J Exp Biol; 1997 Dec 08; 35(12):1319-23. PubMed ID: 9567768
    [Abstract] [Full Text] [Related]

  • 30. Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells.
    Mortaz E, Redegeld FA, Nijkamp FP, Engels F.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):190-3. PubMed ID: 16822499
    [Abstract] [Full Text] [Related]

  • 31. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
    Kruis W, Schreiber S, Theuer D, Brandes JW, Schütz E, Howaldt S, Krakamp B, Hämling J, Mönnikes H, Koop I, Stolte M, Pallant D, Ewald U.
    Gut; 2001 Dec 14; 49(6):783-9. PubMed ID: 11709512
    [Abstract] [Full Text] [Related]

  • 32. IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons.
    Pullman WE, Doe WF.
    Clin Exp Immunol; 1992 Apr 14; 88(1):132-7. PubMed ID: 1563100
    [Abstract] [Full Text] [Related]

  • 33. Cutaneous hypersensitivity reaction to mesalazine.
    Aparicio J, Carnicer F, Girona E, Gmez A.
    Am J Gastroenterol; 1996 Mar 14; 91(3):620-1. PubMed ID: 8633534
    [No Abstract] [Full Text] [Related]

  • 34. [Natural immunostimulants].
    Nikitin AV, Navashin SM.
    Antibiotiki; 1983 Sep 14; 28(9):702-16. PubMed ID: 6357066
    [No Abstract] [Full Text] [Related]

  • 35. Bioavailability of controlled release mesalazine (5-ASA) preparations.
    Rasmussen SN.
    J Gastroenterol; 1995 Nov 14; 30 Suppl 8():112-4. PubMed ID: 8563869
    [Abstract] [Full Text] [Related]

  • 36. [Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
    Benoit R, Grobost O, Bichoffe A, Dol L.
    Gastroenterol Clin Biol; 1999 Mar 14; 23(3):410-1. PubMed ID: 10384350
    [No Abstract] [Full Text] [Related]

  • 37. The effect of some anti-inflammatory drugs on histamine and serotonin release from rat peritoneal mast cells.
    Lipnik-Stangelj M, Ferjan I, Erjavec F.
    Inflamm Res; 1999 Apr 14; 48 Suppl 1():S21-2. PubMed ID: 10350144
    [No Abstract] [Full Text] [Related]

  • 38. Topical mesalazine in the treatment of chemotherapy and radiotherapy-induced oral mucositis.
    Rymes N, Glick L, Holmes JA.
    Bone Marrow Transplant; 1996 Aug 14; 18(2):484. PubMed ID: 8864473
    [No Abstract] [Full Text] [Related]

  • 39. [Fever and hypotension following oral administration of mesalazine].
    Galofré N, Cirera I, Supervía A, Peña MJ.
    Med Clin (Barc); 1995 Mar 11; 104(9):358. PubMed ID: 7731308
    [No Abstract] [Full Text] [Related]

  • 40. Mesalazine during pregnancy.
    Marteau P, Devaux CB.
    Lancet; 1994 Dec 17; 344(8938):1708-9. PubMed ID: 7996988
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.